February 28, 2019
Advancements for breast cancer patients are being led by breast cancer combination therapy innovations, and off-the-shelf personalized immunotherapy
February 3, 2019
The multibillion-dollar immunotherapy market is expected to experience further growth on advancements in checkpoint inhibitor biotechnology.
October 7, 2018
BriaCell CEO Dr. William Williams discusses his company’s success in developing immunotherapies targeting breast and other cancers.